24/10/2014 10:50:43 Free Membership Login

   

AMAG Pharmaceuticals, Inc.

Visual Financials
Company Name: AMAG Pharmaceuticals, Inc.
Ticker Symbol: AMAG
WWW Address: http://www.amagpharma.com
CEO: William Heiden
No. of Employees: 129
Common Issue Type: CS
Business Description:AMAG Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of Feraheme® (ferumoxytol) Injection for Intravenous, or IV, use to treat iron deficiency anemia, or IDA.

 
Industry Information: DRUGS - Diagnostic Support [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 33.85 Up 0.07 33.74 33.87 33.93 34.59 30.58 81405
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 743.3 22.0 0.00 -0.44 0.00 0.0 0.0 34.59 - 16.48
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close33.78$
PE Ratio - LTM0.0
Market Capitalisation743.3mil
Latest Shares Outstanding22.0mil
Earnings pS (EPS)-0.44$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee546,324$
Effective Tax Rate0.0%
Float15.5mil
Float as % of Shares Outstanding0.7%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.70%
Research & Devlopment (R&D) as % of Revenue0.30%
Gross Profit Margin85.2%
EBITDA Margin-10.6%
Pre-Tax Profit Margin0.0%
Assets Turnover30.9%
Return on Assets (ROA)-3.7%
Return on Equity (ROE)-5.6%
Return on Capital Invested (ROCI)-5.6%
Current Ratio7.4
Leverage Ratio (Assets/Equity)1.5
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS9.62$
Cash pS0.00$
Book-Value pS8.79$
Tangible Book-Value pS7.08$
Cash Flow pS-0.31$
Free Cash Flow pS-0.39$
KEY FIGURES (LTM): Price info
Price/Book Ratio3.53
Price/Tangible Book Ratio0.00
Price/Cash Flow-101.0
Price/Free Cash Flow-80.0
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---1.1-4680,5453,926,739
4 Weeks34.5922.5222.7836.037875,81418,392,110
13 Weeks34.5917.8218.5067.569485,76331,574,628
26 Weeks34.5917.1418.0571.668418,98453,630,038
52 Weeks34.5916.4824.2427.816392,29098,857,101
YTD34.5916.48-29.823452,56492,775,818
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
31.5831.0925.7621.2021.180.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue1.110.60.07
Income0.0
Dividend0.0
Capital SpendingNA
R&D7.24NA-7.95
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %15.515.539.4
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $0.400.402.86
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio79.59
Current Ratio7.4
Quick Ratio (Acid Test)6.7
Liquidity Ratio (Cash)7.36
Receivables Turnover12.2
Average Collection Period30
Working Capital/Equity122.5
Working Capital pS9.69
Cash-Flow pS-0.31
Free Cash-Flow pS-0.39
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio5.45
Financial Leverage Ratio (Assets/Equity)0.0
Debt Ratio0.0
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested34.8
LT Debt/Total Liabilities0.0
Interest Cover0.0
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio2.57
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-45.65
Enterprise Value (EV)/Free Cash Flow-61.64
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM3.53
Price/Cash Flow Ratio-101.0
Price/Free Cash Flow Ratio - LTM-80.0
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio-92.2
5-Y Low P/E Ratio-21.8
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS2.13
Tangible Book Value pS - LTM7.08
Book Value pS - LTM8.79
Capital Invested pS7.85
Cash pS - LTM0.00
Cash Flow pS - LTM-0.31
Free Cash Flow pS - LTM-0.39
Earnings pS (EPS)-0.44
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-10.40
Free Cash Flow Margin 5YEAR AVG-133.11
Net Profit Margin-0.1
Net Profit Margin - 5YEAR AVRG.-1.6
Equity Productivity0.47
Return on Equity (ROE)-0.1
Return on Equity (ROE) - 5YEAR AVRG.-0.3
Capital Invested Productivity0.47
Return on Capital Invested (ROCI)-0.3
Return on Capital Invested (ROCI) - 5YEAR AVRG.-0.3
Assets Productivity0.30
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.-0.2
Gross Profit Margin85.2
Gross Profit Margin - 5YEAR AVRG.0.9
EBITDA Margin - LTM-10.6
EBIT Margin - LTM-14.4
Pre-Tax Profit Margin-1.7
Pre-Tax Profit Margin - 5YEAR AVRG.-1.7
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.1.7
EFFICIENCY RATIOS
Cash Conversion Cycle238,039
Revenue per Employee546,324
Net Income per Employee
Average Collection Period238,039
Receivables Turnover12.2
Day's Inventory Turnover Ratio
Inventory Turnover0.8
Inventory/Sales21.3
Accounts Payble/Sales3.25
Assets/Revenue3.33
Net Working Capital Turnover0.38
Fixed Assets Turnover3.84
Total Assets Turnover0.3
Revenue per $ Cash3.00
Revenue per $ Plant43.80
Revenue per $ Common Equity0.47
Revenue per $ Capital Invested0.47
Selling, General & Adm/tive (SG&A) as % of Revenue74.1
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue25.4
R&D Expense as % of Revenue - 5YEAR AVRG.25.4

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq amag141024 10:50